Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Expensify (EXFY) Asset Writedowns and Impairment (2020 - 2025)

Historic Asset Writedowns and Impairment for Expensify (EXFY) over the last 6 years, with Q3 2025 value amounting to $148000.0.

  • Expensify's Asset Writedowns and Impairment rose 724.64% to $148000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $563000.0, marking a year-over-year increase of 255.01%. This contributed to the annual value of $547000.0 for FY2024, which is 1091.21% down from last year.
  • Latest data reveals that Expensify reported Asset Writedowns and Impairment of $148000.0 as of Q3 2025, which was up 724.64% from $141000.0 recorded in Q2 2025.
  • Expensify's 5-year Asset Writedowns and Impairment high stood at $189000.0 for Q4 2021, and its period low was $135000.0 during Q4 2022.
  • Moreover, its 5-year median value for Asset Writedowns and Impairment was $148000.0 (2025), whereas its average is $157631.6.
  • Per our database at Business Quant, Expensify's Asset Writedowns and Impairment tumbled by 2857.14% in 2022 and then skyrocketed by 724.64% in 2025.
  • Over the past 5 years, Expensify's Asset Writedowns and Impairment (Quarter) stood at $189000.0 in 2021, then fell by 28.57% to $135000.0 in 2022, then grew by 2.22% to $138000.0 in 2023, then fell by 1.45% to $136000.0 in 2024, then increased by 8.82% to $148000.0 in 2025.
  • Its Asset Writedowns and Impairment stands at $148000.0 for Q3 2025, versus $141000.0 for Q2 2025 and $138000.0 for Q1 2025.